ஆக்ஸ்ஃபர்ட் புற்றுநோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆக்ஸ்ஃபர்ட் புற்றுநோய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆக்ஸ்ஃபர்ட் புற்றுநோய் Today - Breaking & Trending Today

Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021


Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update
May 20, 2021 08:00 ET
| Source:
Replimune Group Inc
Replimune Group Inc
Woburn, Massachusetts, UNITED STATES
Added complete response as an independent primary endpoint in registration-directed CERPASS study in CSCC and held Type B meeting with FDA to discuss the IGNYTE study in anti-PD1 failed melanoma
Dosed first patient with RP1 in the anti-PD1 failed NSCLC lung cancer cohort of the IGNYTE study
Data update on lead programs to be provided during virtual investor event on June 3, 2021 
Strengthened management team to prepare for potential commercial launch and enable further later stage development ....

United States , Mark Middleton , Philip Astley Sparke , Sushil Patel , Company Phase , University Of Oxford , Head Of The Department Oncology , Development Operations Officer , Replimune Group Inc , Hematology Centre , American Association For Cancer Research , Department Of Oncology , Chief Commercial Officer , Tanya Lewis , Chief Development Operations , Cancer Research , Investor Event , Experimental Cancer Medicine , Medical Oncologist , Oxford Cancer , Nasdaq Repl , Replimune Group Inc , ஒன்றுபட்டது மாநிலங்களில் , குறி மிடில்டன் , பிலிப் அஸ்டலே ஸ்பார்க் , சுஷில் படேல் ,